1. Home
  2. OFG vs ANIP Comparison

OFG vs ANIP Comparison

Compare OFG & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFG
  • ANIP
  • Stock Information
  • Founded
  • OFG 1964
  • ANIP 2001
  • Country
  • OFG United States
  • ANIP United States
  • Employees
  • OFG N/A
  • ANIP N/A
  • Industry
  • OFG Major Banks
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • OFG Finance
  • ANIP Health Care
  • Exchange
  • OFG Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • OFG 1.9B
  • ANIP 2.0B
  • IPO Year
  • OFG N/A
  • ANIP N/A
  • Fundamental
  • Price
  • OFG $44.80
  • ANIP $91.01
  • Analyst Decision
  • OFG Buy
  • ANIP Strong Buy
  • Analyst Count
  • OFG 3
  • ANIP 9
  • Target Price
  • OFG $46.67
  • ANIP $82.89
  • AVG Volume (30 Days)
  • OFG 219.0K
  • ANIP 738.5K
  • Earning Date
  • OFG 10-15-2025
  • ANIP 08-08-2025
  • Dividend Yield
  • OFG 2.68%
  • ANIP N/A
  • EPS Growth
  • OFG 4.40
  • ANIP N/A
  • EPS
  • OFG 4.25
  • ANIP N/A
  • Revenue
  • OFG $619,470,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • OFG N/A
  • ANIP $31.40
  • Revenue Next Year
  • OFG $1.89
  • ANIP $7.38
  • P/E Ratio
  • OFG $10.55
  • ANIP N/A
  • Revenue Growth
  • OFG N/A
  • ANIP 38.68
  • 52 Week Low
  • OFG $33.15
  • ANIP $52.50
  • 52 Week High
  • OFG $47.66
  • ANIP $92.33
  • Technical
  • Relative Strength Index (RSI)
  • OFG 62.26
  • ANIP 80.64
  • Support Level
  • OFG $42.56
  • ANIP $85.44
  • Resistance Level
  • OFG $43.51
  • ANIP $91.15
  • Average True Range (ATR)
  • OFG 0.80
  • ANIP 3.38
  • MACD
  • OFG 0.16
  • ANIP 1.12
  • Stochastic Oscillator
  • OFG 98.61
  • ANIP 94.54

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: